Multiple Myeloma Market: Meeting the Needs of Patients Across Relapsed/Refractory and Newly Diagnosed Settings
A new market analysis highlights the significant expansion anticipated in the global Multiple Myeloma Market. Valued at USD 23.20 billion in 2023, the market is projected to grow from USD 25.17 billion in 2024 to a substantial USD 44.82 billion by 2031, exhibiting a robust Compound Annual Growth Rate (CAGR) of 8.59% during the forecast period. This growth is primarily driven by the increasing...
0 Bình luận
0 Chia sẻ
14 Lượt xem
English
العربية
Français
Español
Português
Deutsch
Türkçe
Nederlands
Italiano
Русский
Română
Português
Ελληνικά